|John Nemunaitis, M.D., Co-founder and Chief Scientific Officer||
Dr. Nemunaitis specializes in medical oncology and hematology and is board certified in internal medicine. He is an Oncologist and currently the Executive Medical Director of Mary Crowley Cancer Research Centers, and has been exploring therapies for cancer treatments for over 20 years. Dr. Nemunaitis previously held academic positions at Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine. He is a member of the board of directors of the American Cancer Society of Gene and Cell Therapy, is a committee member of the Western Institutional Review Board, and is on the editorial board of several peer reviewed journals focusing on cancer and molecular sciences. Dr. Nemunaitis has authored 314 peer-reviewed publications and 44 book chapters. Dr. Nemunaitis received an M.D. from Case Western Reserve University School of Medicine, Ohio. He completed training in internal medicine at Boston City Hospital and a fellowship in oncology and hematology at University of Washington School of Medicine and Fred Hutchinson Cancer Research Center in Seattle.